文献速递系统性红斑狼疮

干扰素激活状态与轻治疗系统性红斑狼疮患者对病毒抗原的高抗体应答相关

Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

本研究在拆分病毒体流感疫苗接种期间随访未治疗或仅用羟氯喹和/或低剂量泼尼松的女性SLE患者(n=29)及年龄性别匹配的健康对照(n=17),发现患者疫苗特异性抗体应答显著高于对照,且接种前mRNA干扰素评分阳性与更高的疫苗特异性抗体应答及更广泛的自体抗体谱相关。

要点

  • 轻治疗SLE患者对流感疫苗的抗体应答高于健康对照。
  • 接种前mRNA干扰素评分阳性与更高疫苗抗体应答和更广泛自体抗体相关。
  • 血清干扰素调节蛋白水平与疫苗特异性IgG应答相关。

核心结论

  • 未治疗或轻治疗的SLE患者对病毒抗原产生增强的抗体应答,并与I型干扰素系统在RNA和蛋白水平的激活标志相关。

研究设计与样本

  • 研究纳入未治疗或仅用羟氯喹和/或低剂量泼尼松的女性SLE患者29例及年龄性别匹配的健康对照17例,在拆分病毒体流感疫苗接种期间采集血样和临床数据。

主要发现

  • 患者疫苗特异性抗体应答显著高于对照,免疫后1个月和3个月针对病毒蛋白的IgG滴度均高于对照。
  • 研究期间临床疾病症状和自体抗体滴度保持不变。
  • 接种前mRNA干扰素评分阳性与显著更高的疫苗特异性抗体应答及更广泛的自体抗体特异性谱相关。
  • 患者血清中干扰素调节蛋白水平高于对照,且这些蛋白水平与疫苗特异性IgG应答相关,其中C-C基序趋化因子配体3关联最强。

临床怎么用

  • 对于未治疗或轻治疗的SLE患者,接种流感疫苗后抗体应答可能增强,但需结合干扰素激活状态评估个体免疫反应。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Infections have been proposed as an environmental risk factor for autoimmune disease. Responses to microbial antigens may be studied in vivo during vaccination. We therefore followed patients with SLE and controls during split-virion influenza vaccination to quantify antibody responses against viral antigens and associated cellular and proteome parameters. METHODS: Blood samples and clinical data were collected from female patients with SLE with no or HCQ and/or low-dose prednisolone treatment (n = 29) and age- and sex-matched healthy controls (n = 17). Vaccine-specific antibody titres were measured by ELISA and IFN-induced gene expression in monocytes by quantitative PCR. Serum proteins were measured by proximity extension assay and disease-associated symptoms were followed by questionnaires. RESULTS: The vaccine-specific antibody response was significantly higher in patients compared with controls and titres of IgG targeting the viral proteins were higher in patients than controls at both 1 and 3 months after immunization. Clinical disease symptoms and autoantibody titres remained unchanged throughout the study. Notably, a positive pre-vaccination mRNA-based IFN score was associated with a significantly higher vaccine-specific antibody response and with a broader profile of autoantibody specificities. Screening of serum protein biomarkers revealed higher levels of IFN-regulated proteins in patients compared with controls and that levels of such proteins correlated with the vaccine-specific IgG response, with C-C motif chemokine ligand 3 exhibiting the strongest association. CONCLUSION: Augmented antibody responses to viral antigens develop in patients with SLE on no or light treatment and associate with markers of type I IFN system activation at the RNA and protein levels.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Björk A, Da Silva Rodrigues R, Richardsdotter Andersson E, et al. Interferon activation status underlies higher antibody response to viral antigens in patients with systemic lupus erythematosus receiving no or light treatment. Rheumatology (Oxford). 2021. PMID: 33006609. doi:10.1093/rheumatology/keaa611

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。